SCHEMBL4478739

SCHEMBL4478739

Cc1[nH]c(C)c(-c2ccc(-c3ccc(Cl)cc3)nc2)c(=O)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.47
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
BRD4 O60885 1/20 0.37
RUNX1 Q01196 1/20 0.37
CBFB Q13951 1/20 0.37
KDM1A O60341 1/20 0.37
MAOB P27338 1/20 0.37
MAPK1 P28482 1/20 0.35
CNR2 P34972 1/20 0.35
MAPT P10636 2/20 0.35
KDM5B Q9UGL1 1/20 0.35
PSD A5PKW4 2/20 0.34
METAP2 P50579 1/20 0.34
NOTUM Q6P988 1/20 0.34
IKBKB O14920 1/20 0.34
MAP3K14 Q99558 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13754687 0.90 HPGDS (0.43) SLC2A1KDM4EMEN1KMT2AMAPT
SCHEMBL4475363 0.89 NPC1 (0.40) SLC2A1MEN1KMT2AKDM5BPSD
SCHEMBL4481800 0.87 RXFP1 (0.45) SLC2A1ALDH1A1BRD4NPC1RAB9A
SCHEMBL3425836 0.87 CYP11B1 (0.37) SLC2A1KDM4EALDH1A1BRD4SMN1; SMN2
SCHEMBL4487868 0.86 SLC2A1 (0.45) SLC2A1KDM4EALDH1A1GAAMEN1
SCHEMBL3392235 0.86 KDM1A (0.39) SLC2A1KDM1AMAPTGRIN1GRIN2B
SCHEMBL4565033 0.86 SLC2A1 (0.43) SLC2A1KDM4EKDM1AMAOB
SCHEMBL4490539 0.86 KDM1A (0.41) SLC2A1GAAMEN1KMT2AKDM1A
SCHEMBL4483589 0.86 SLC2A1 (0.34) SLC2A1NOTUM
SCHEMBL9265685 0.83 SLC2A1 (0.62) SLC2A1KDM4EALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US claimed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US claimed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP SLC2A1 2278/4885KDM4E 1311/4885ALDH1A1 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.